Global blood collection market is witnessing sustained growth as diagnostic testing becomes central to modern healthcare delivery. Valued at USD 4.97 billion in 2024, the market is projected to reach USD 8.24 billion by 2031, expanding at a CAGR of 7.7% over the forecast period. This growth reflects increasing reliance on laboratory diagnostics, preventive healthcare practices, and safety-engineered medical devices across hospitals, laboratories, and decentralized care settings worldwide.
Access complete report https://www.24lifesciences.com/blood-collection-market-7695
Emerging Healthcare Trends Influencing the Blood Collection Market
In 2025, the blood collection market is increasingly shaped by automation, safety innovation, and decentralized diagnostics. The integration of automated laboratory systems has elevated the demand for standardized blood collection tubes compatible with high-throughput analyzers. At the same time, point-of-care and home-based testing models are accelerating the use of minimally invasive capillary blood collection methods, improving patient comfort and accessibility.
Regulatory focus on healthcare worker safety is also influencing product development, with safety-engineered needles and closed-system devices becoming standard in many regions. Global health organizations continue to emphasize safe blood practices as a foundation of effective healthcare systems, reinforcing long-term market stability and adoption
Key Market Drivers Supporting Industry Growth
Several structural and clinical factors are driving expansion of the blood collection market:
- Rising diagnostic testing volumes: Chronic diseases, aging populations, and preventive screening programs require frequent blood analysis.
- Shift toward decentralized healthcare: Growth in ambulatory centers, home healthcare, and point-of-care testing boosts demand for flexible collection solutions.
- Safety and quality standards: Adoption of safety-engineered devices reduces needle-stick injuries and contamination risks.
- Laboratory automation: Modern diagnostic workflows require high-quality, standardized collection tubes and additives.
Together, these drivers ensure consistent demand across both developed and emerging healthcare systems.
Download Insights https://www.24lifesciences.com/download-sample/7695/blood-collection-market
Competitive Landscape: Leading Companies Advancing Blood Collection Technologies
The global blood collection market features established medical device manufacturers focused on safety, reliability, and workflow efficiency. Key players include:
- Becton Dickinson – A global leader in safety-engineered blood collection systems and diagnostic solutions.
- Terumo – Innovating advanced blood collection and transfusion technologies with strong global reach.
- Greiner Bio-One – Specializing in high-quality vacuum blood collection tubes and laboratory consumables.
- Medtronic – Leveraging expertise in medical devices to support integrated clinical workflows.
- SEKISUI Medical – Providing specialized diagnostic materials and advanced blood collection products.
These companies are strengthening market positions through continuous R&D investment, product launches, and global distribution expansion.
Segment Insights & Regional Overview
By type, serum separating tubes and EDTA tubes dominate the market, forming the backbone of routine diagnostic testing due to their reliability and standardized use. Plasma separation tubes are gaining traction for specialized testing, while niche and advanced tubes offer innovation opportunities.
By application, capillary blood collection is a leading segment, driven by minimally invasive testing and decentralized care models. Venous blood collection remains essential for obtaining larger sample volumes required in hospitals and diagnostic laboratories.
By end user, hospitals and diagnostic laboratories account for the largest market share due to high testing volumes. Blood banks maintain consistent demand for transfusion medicine, while academic and research institutes support ongoing clinical and biomedical research. Growth in ambulatory and home healthcare settings highlights the market’s decentralization trend.
Regionally, North America leads the blood collection market, supported by advanced healthcare infrastructure, strict regulatory standards, and widespread diagnostic testing. Europe represents a mature and highly regulated market with strong emphasis on blood safety and quality. Asia-Pacific is the fastest-growing region, driven by expanding healthcare access, large population bases, and rapid modernization of hospital infrastructure. South America and the Middle East & Africa present developing to emerging markets, shaped by healthcare investment, blood safety initiatives, and economic growth.
Explore Analysis https://www.24lifesciences.com/blood-collection-market-7695
Technological Advancements & Strategic Outlook
Can Automation and Safety-Engineered Devices Redefine Blood Collection Practices?
The future of the blood collection market lies in automation, material innovation, and workflow optimization. Plastic tubes with advanced additives and separation gels are increasingly preferred for their safety and compatibility with automated systems. As laboratories prioritize efficiency and accuracy, manufacturers focusing on integrated, user-friendly solutions are well positioned to capture long-term value.
Key Benefits of the 24LifeSciences Blood Collection Market Report
- Comprehensive segmentation analysis across type, application, end user, material, and additives
- Market size forecasts and CAGR insights through 2031
- Competitive benchmarking of major global players
- Strategic perspectives on emerging opportunities in decentralized diagnostics
Stay ahead https://www.24lifesciences.com/blood-collection-market-7695
Future Perspective
As healthcare systems increasingly rely on diagnostics for prevention, monitoring, and treatment decisions, the blood collection market remains a foundational pillar of modern medicine. With steady growth, technological refinement, and expanding global access, the market offers meaningful opportunities for manufacturers, healthcare providers, and policymakers committed to advancing safe and efficient diagnostic care.
About 24lifesciences
Founded in 2017, 24LifeScience has emerged as a trusted research and analytics partner for organizations operating within the global life sciences and chemical industries. Our core mission is to provide intelligent, future-ready insights that help clients stay ahead in an increasingly complex and innovation-driven market
International: +1(332) 2424 294 | Asia: +91 9425150513 (Asia)
Website: http://www.24lifesciences.com
Follow us on LinkedIn: http://www.linkedin.com/company/lifesciences24
- Single-Domain Heavy Chain Antibody Market - 2026-01-23
- Qianlie Antong Capsules Market - 2026-01-23
- Veterinary Amitraz Solution Market - 2026-01-23